Assam reports 5,347 fresh Covid cases, 63 more fatalities in last 24 hours

Assam's Covid-19 tally mounted to 3,24,979 on Saturday as 5,347 more people tested positive for the disease, while 63 fresh fatalities pushed the coronavirus death toll to 2,123

Topics
Coronavirus Vaccine | Coronavirus | Lockdown

Press Trust of India  |  Guwahati 

Assam's COVID-19 tally mounted

to 3,24,979 on Saturday as 5,347 more people tested positive for the disease, while 63 fresh fatalities pushed the death toll to 2,123, a bulletin issued by the National Health Mission here said.

Kamrup (Metro) recorded the highest number of new fatalities at 21, followed by Dibrugarh and Cachar at five each, Bongaigaon, Kamrup (Rural) and Karbi Anglong at three each and Barpeta, Nalbari, Darrang, Golaghat and Sonitpur at two each.

The remaining deaths were reported from several other districts.

At least 1,347 COVID-19 patients died in the state due to other ailments, the bulletin said.

The new cases include 1,012 from Kamrup Metro, 424 from Kamrup (Rural), 343 from Nagaon and 291 from Sontipur.

The fresh COVID cases were detected out of 64,701 tests conducted during the day with the positivity rate at 8.26 per cent, it said.

Overall 94,49,818 samples have so far been tested for COVID-19 in the state.

Assam now has 44,008 active cases.

At least 3,254 people were cured of the disease during the day, pushing the total number of recoveries to 2,77,501.

The recovery rate among patients in the state stands at 85.39 per cent.

Altogether, 33,61,495 people have been inoculated in Assam, with 7,30,846 of them having received both doses of the COVID-19 vaccine.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Read our full coverage on Coronavirus Vaccine
First Published: Sun, May 16 2021. 09:23 IST
RECOMMENDED FOR YOU